New York State Teachers Retirement System (NYSTRS)’s Coherus Oncology CHRS Stock Holding History

New York State Teachers Retirement System (NYSTRS)’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-32,690	Closed	-$140K	–	1615
2023 Q2	$140K	Hold	32,690	–	–	﹤0.01%	1537
2023 Q1	$224K	Sell	32,690 -1,100	-3%	-$8.54K	﹤0.01%	1507
2022 Q4	$268K	Sell	33,790 -200	-0.6%	-$1.54K	﹤0.01%	1488
2022 Q3	$327K	Sell	33,990 -164	-0.5%	-$1.66K	﹤0.01%	1454
2022 Q2	$247K	Hold	34,154	–	–	﹤0.01%	1497
2022 Q1	$441K	Hold	34,154	–	–	﹤0.01%	1441
2021 Q4	$545K	Hold	34,154	–	–	﹤0.01%	1415
2021 Q3	$549K	Hold	34,154	–	–	﹤0.01%	1429
2021 Q2	$472K	Sell	34,154 -13,903	-29%	-$197K	﹤0.01%	1428
2021 Q1	$702K	Sell	48,057 -4,197	-8%	-$71.3K	﹤0.01%	1375
2020 Q4	$908K	Sell	52,254 -100	-0.2%	-$1.78K	﹤0.01%	1307
2020 Q3	$960K	Buy	52,354 +12,306	+31%	+$229K	﹤0.01%	1227
2020 Q2	$715K	Buy	+40,048	New	+$678K	﹤0.01%	1277

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)'s CHRS Position: Q3 2023 in Review

New York State Teachers Retirement System (NYSTRS) sold out of Coherus Oncology (CHRS) in Q3 2023, closing a stake of 32,690 shares — an estimated $140K sold.

New York State Teachers Retirement System (NYSTRS) first reported a position in CHRS in Q2 2020 and held it in 13 quarters. The position peaked at $960K in Q3 2020. 169 funds tracked by Wall St. Rank hold CHRS as of Q3 2023.

New York State Teachers Retirement System (NYSTRS) reported no remaining Coherus Oncology position as of Q3 2023 after selling out during the quarter.
New York State Teachers Retirement System (NYSTRS) sold 32,690 Coherus Oncology shares in Q3 2023, an estimated $140K.
New York State Teachers Retirement System (NYSTRS) first reported a position in Coherus Oncology in Q2 2020 and held it in 13 quarters.
New York State Teachers Retirement System (NYSTRS)'s Coherus Oncology position peaked at $960K in Q3 2020.
169 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2023.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q3 2023, filed 25 Oct 2023.